Valneva (VALN)

• Market cap: $549M
• 1 day: 0.75%
• 5 days: -5.72%
• 1 month: -0.88%
• 3 months: 43.22%
• 6 months: 17.16%
• Year to date: 43.22%
• 1 year: -11.98%
• 5 years: -76.16%
• 10 years: -76.16%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

20% more funds holding

Funds holding: 10 [Q3] → 12 (+2) [Q4]

0% more ownership

Funds ownership: 0.44% [Q3] → 0.44% (+0%) [Q4]

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

27% less capital invested

Capital invested by funds: $4.35M [Q3] → $3.16M (-$1.19M) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $15 122% upside
• Avg. target: $16 137% upside
• High target: $17 151% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Edward White 27% 1-year accuracy 40 / 149 met price target	151% upside $17	Buy Reiterated	31 Mar 2025
Guggenheim Dana Flanders 0% 1-year accuracy 0 / 1 met price target	122% upside $15	Buy Maintained	24 Mar 2025